Use of MGC4504

Details for Australian Patent Application No. 2006222204 (hide)

Owner Sanofi-Aventis

Inventors Tschank, Georg; Korn, Marcus Hermann; Voss, Marc Dietrich

Agent Watermark

Pub. Number AU-B-2006222204

PCT Pub. Number WO2006/094735

Priority 5005383.4 11.03.05 EP

Filing date 6 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 27 September 2012

International Classifications

G01N 33/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/094735 Priority application(s): WO2006/094735

27 September 2012 Application Accepted

  Published as AU-B-2006222204

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222206-Gastroresistant pharmaceutical formulations containing rifaximin

2006222193-Screening method, process for purifying of non-diffusible A-beta oligomers, selective antibodies against said nondiffusible A-beta oligomers and a process for manufacturing of said antibodies